Histogen HSTO Patent; Sarepta SRPT Advisory Committee Planned
Crude Oil Down 2%; Enzo Biochem Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 300 points on Friday. The Dow traded down 1.07% to 31,899.93 while the NASDAQ fell 0.68% to 11,638.13. The S&P 50
First Republic Bank's Stock Plunge Continues Despite $30 Billion Bank Boost, FedEx's Stock Jumps After Blowout Earnings Report
By Anviksha Patel and Tomi Kilgore FedEx stock soars after beating fiscal third-quarter estimates and lifting its full-year outlook These were some of the biggest movers and shakers in Friday tradin
Why Are Histogen Shares Trading Higher Today?
The U.S. Patent and Trademark Office (USPTO) has issued US Patent providing broad coverage for Histogen Inc's (NASDAQ:HSTO) portfolio of anti-inflammatory caspase inhibitors, including CTS-2090. This
Histogen Gets US Patent Offering Broad Coverage for Anti-Inflammatory Caspase Inhibitors; Shares Rise Pre-Bell Friday
09:29 AM EDT, 03/17/2023 (MT Newswires) -- Histogen (HSTO) said late Thursday that the US Patent and Trademark Office issued a patent that offers broad coverage for the company's anti-inflammatory cas
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersEnzo Biochem (NYSE:ENZ) shares moved upwards by 79.8% to $2.14 during Friday's pre-market session. The market value of their outstanding shares is at $104.2 million. MiNK Therapeutics (NASDAQ:I
Top Premarket Gainers
07:50 AM EDT, 03/17/2023 (MT Newswires) -- Enzo Biochem (ENZ) shares were up more than 76% early Friday, a day after the company said it agreed to sell its clinical laboratory division to Laboratory C
Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket
Gainers Enzo Biochem, Inc. (NYSE:ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp.Histogen Inc. (NASDAQ:HSTO) climbed 3
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersEnzo Biochem (NYSE:ENZ) stock rose 104.2% to $2.43 during Thursday's after-market session. At the close, Enzo Biochem's trading volume reached 1.2 million shares. This is 2239.4% of its average
Histogen Announces Issuance Of US Patent Covering CTS-2090 Methods Of Use
Histogen Announces Issuance Of US Patent Covering CTS-2090 Methods Of Use